Product NDC: | 55390-244 |
Proprietary Name: | Pentostatin |
Non Proprietary Name: | Pentostatin |
Active Ingredient(s): | 10 mg/5mL & nbsp; Pentostatin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-244 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077841 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070813 |
Package NDC: | 55390-244-01 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 BOX (55390-244-01) > 5 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 55390-244-01 |
Proprietary Name | Pentostatin |
Package Description | 1 VIAL, SINGLE-DOSE in 1 BOX (55390-244-01) > 5 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 55390-244 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pentostatin |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20070813 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | PENTOSTATIN |
Strength Number | 10 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |